Deferoxamine

tumor necrosis factor ; Mus musculus







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29678877 Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob/ob mice. 2018 Apr 1
2 25361473 Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells. 2015 May 2
3 25644393 Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice. 2015 Feb 3 1
4 26277391 Deferoxamine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxic shock in mice. 2015 Sep 18 1
5 17883261 Biological effects of particles from the paris subway system. 2007 Oct 1
6 18025230 Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276. 2007 Dec 1 2
7 14961065 Picolinic acid- or desferrioxamine-inducible autocrine activation of macrophages engineered to produce IFNgamma: an approach for gene therapy. 2004 Mar 1
8 10988358 Deferoxamine reduces tissue injury and lethality in LPS-treated mice. 2000 Aug 4
9 10569191 Dependence of NF-kappaB activation and free radical generation on silica-induced TNF-alpha production in macrophages. 1999 Oct 1
10 7622893 Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages. 1995 Aug 2
11 7790027 DNA damage induced by tumour necrosis factor-alpha in L929 cells is mediated by mitochondrial oxygen radical formation. 1995 Apr 1
12 8324080 The role of iron in the cytotoxicity of tumor necrosis factor. 1993 Apr 1
13 1550349 Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. 1992 Apr 1
14 2745981 Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. 1989 Aug 15 2